Astellas Pharma Inc. (TYO:4503)
1,660.00
+35.50 (2.19%)
Oct 6, 2025, 3:30 PM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 2.97 trillion as of October 6, 2025. Its market cap has decreased by -7.97% in one year.
Market Cap
2.97T
Enterprise Value
3.65T
Revenue
1.94T
Ranking
n/a
PE Ratio
36.57
Stock Price
1,660.00
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 2.97T, an increase of 236.63%. That is a compound annual growth rate of 3.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 2,908.36B | 5.88% |
Dec 30, 2024 | 2,746.92B | -9.13% |
Dec 29, 2023 | 3,022.77B | -17.34% |
Dec 30, 2022 | 3,657.07B | 5.52% |
Dec 30, 2021 | 3,465.82B | 17.06% |
Dec 30, 2020 | 2,960.81B | -15.46% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 11.91T |
HOYA Corporation | 7,289.18B |
Daiichi Sankyo Company | 7,227.93B |
Takeda Pharmaceutical Company | 6,650.97B |
Otsuka Holdings | 4,453.20B |
Terumo | 3,603.56B |
Shionogi & | 2,211.28B |
Olympus | 2,151.51B |